title: Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
authors.forename: I
authors.initials: I
authors.lastname: Anghelescu
authors.forename: C
authors.initials: C
authors.lastname: Klawe
authors.forename: H
authors.initials: H
authors.lastname: Himmerich
authors.forename: A
authors.initials: A
authors.lastname: Szegedi
mesh_terms: D000379:Agoraphobia / Q000523:psychology; D000437:Alcoholism / Q000523:psychology; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D020762:Infarction, Posterior Cerebral Artery / Q000150:complications* / Q000523:psychology; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000077236:Topiramate; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D005632:Fructose; D018696:Neuroprotective Agents; D017367:Selective Serotonin Reuptake Inhibitors; D000077236:Topiramate; D000069470:Venlafaxine Hydrochloride